Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Algorithms give computers step-by-step instructions to complete tasks accurately.Good algorithms improve software speed, ...

Anthropic recursive self improvement, Brian Patrick Green tech ethics, AI regulation slowdown, Pope Leo XIV AI encyclical, ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Comcast said it will split into two companies for "flexibility," which may be Brian Roberts' code for "future dealmaking." Who might be suitable candidates for a deal?

A Catholic expert on artificial intelligence is commending recent calls by AI research firm Anthropic to rein in the technology amid a significant acceleration in its growth.

Google DeepMind's new report maps four pathways from AGI to artificial superintelligence. Here's how scaling, paradigm shifts ...

Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...